Delivery Order SPE2DR25D2214-SPE2DR26FV5S7
- Not listed
- The Defense Logistics Agency awarded a $1,223.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product, with an ultimate completion date of October 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on November 3, 2025, with an ultimate completion date of November 25, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 3, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed-price delivery order, issued on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive with no set-aside designation and...
- The Defense Logistics Agency awarded a $1,184.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of November 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of XDEMVY 0.25% DROP 10ML pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by October 16, 2025. The contract is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters, and does not utilize a set-aside designation. As a child contract, this...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency (DLA) for 0.25% XDEMVY drop in a 10 milliliter formulation, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This firm fixed-price delivery order, issued on October 30, 2025, is scheduled for completion by November 21, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in Conshohocken, PA 19428. This...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV5S7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 25, 2025. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC enables it to supply a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. This delivery order exemplifies the company's role in fulfilling federal medical supply requirements through the DLA's pharmaceutical support network, which encompasses both specialty and generic medications, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/3/25 |